TY - JOUR
T1 - Functional diversity of myeloid-derived suppressor cells
T2 - The multitasking hydra of cancer
AU - Jayakumar, Asha
AU - Bothwell, Alfred L.M.
N1 - Publisher Copyright:
© 2019 American Association of Immunologists. All rights reserved.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Myeloid-derived suppressor cells (MDSCs) are immature suppressive cells found in tumors and immunological niches. In this article, we highlight the ability of MDSCs to promote IL-17–producing T cells (Th17) and regulatory T cells in addition to suppressing cytotoxic T cells in different tumor models. These interactions between MDSCs and T cells support tumor growth because IL-17 is tumorigenic in many cancer types and regulatory T cells suppress antitumor T cells. Besides T cells, MDSCs promote regulatory B cells and suppress overall B cell function; however, tumor-evoked regulatory B cells also regulate MDSC function, suggesting cross-regulation between MDSCs and B cells. These multiple functions shed light on how MDSCs dysregulate several arms of host immune response. Moreover, MDSCs promote tumor cell survival and angiogenesis to support tumors. Therefore, the multifunctionalfeature of MDSCs make them attractive immunotherapeutictargets.
AB - Myeloid-derived suppressor cells (MDSCs) are immature suppressive cells found in tumors and immunological niches. In this article, we highlight the ability of MDSCs to promote IL-17–producing T cells (Th17) and regulatory T cells in addition to suppressing cytotoxic T cells in different tumor models. These interactions between MDSCs and T cells support tumor growth because IL-17 is tumorigenic in many cancer types and regulatory T cells suppress antitumor T cells. Besides T cells, MDSCs promote regulatory B cells and suppress overall B cell function; however, tumor-evoked regulatory B cells also regulate MDSC function, suggesting cross-regulation between MDSCs and B cells. These multiple functions shed light on how MDSCs dysregulate several arms of host immune response. Moreover, MDSCs promote tumor cell survival and angiogenesis to support tumors. Therefore, the multifunctionalfeature of MDSCs make them attractive immunotherapeutictargets.
UR - http://www.scopus.com/inward/record.url?scp=85071497604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071497604&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1900500
DO - 10.4049/jimmunol.1900500
M3 - Review article
C2 - 31427398
AN - SCOPUS:85071497604
SN - 0022-1767
VL - 203
SP - 1095
EP - 1103
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -